The transcription elongation factor TCEA3 promotes the activity of the myogenic regulatory factors.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 25 02 2019
accepted: 17 05 2019
entrez: 4 6 2019
pubmed: 4 6 2019
medline: 12 2 2020
Statut: epublish

Résumé

The transcription elongation factor TFIIS is encoded by a three member gene family in vertebrates. Here we show that one member of this family, TCEA3, is upregulated during skeletal muscle differentiation and acts to promote gene activation by the myogenic regulatory family of transcription factors, which includes MyoD and myogenin. We show that myogenin is a direct regulator of Tcea3. Myogenin binds to the Tcea3 promoter and is required to recruit RNA polymerase II. TCEA3 can bind to both myogenin and MyoD and is co-recruited with the MRFs to promoters dependent on the MRFs. Depletion of myogenin inhibits the recruitment of TCEA3, suggesting that the interaction of TCEA3 with the MRFs serves to aid in recruitment to target promoters. Like TFIIS, we show that TCEA3 interacts with RNA polymerase II. TCEA3 travels with the elongating RNA polymerase II in the coding region of genes and depletions of TCEA3 inhibit the recruitment of RNA polymerase II to promoters. In proliferating cells, TCEA3 expressed at low levels and is present in both the nucleus and cytoplasm. However, upon differentiation, TCEA3 is upregulated and transported exclusively to the nucleus. Thus, our data show that TCEA3 is a required co-factor for MRF driven gene expression during myogenesis.

Identifiants

pubmed: 31158246
doi: 10.1371/journal.pone.0217680
pii: PONE-D-19-05590
pmc: PMC6546274
doi:

Substances chimiques

Myogenic Regulatory Factors 0
RNA, Messenger 0
Transcriptional Elongation Factors 0
transcription factor S-II 0
RNA Polymerase II EC 2.7.7.-

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0217680

Subventions

Organisme : NIAMS NIH HHS
ID : R15 AR068622
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6340-5
pubmed: 20308542
Med Sci Monit. 2015 Oct 26;21:3241-6
pubmed: 26498664
Cell. 1987 Dec 24;51(6):987-1000
pubmed: 3690668
Skelet Muscle. 2011 Apr 04;1(1):14
pubmed: 21798092
Histol Histopathol. 2000 Apr;15(2):649-56
pubmed: 10809386
Gene Expr. 2013;16(1):25-30
pubmed: 24397209
J Cell Physiol. 2019 Jul;234(7):10554-10565
pubmed: 30623413
Trends Genet. 2003 Oct;19(10):543-50
pubmed: 14550628
Cell Signal. 2013 May;25(5):1245-51
pubmed: 23357533
J Biol Chem. 2000 Nov 24;275(47):36541-9
pubmed: 10940308
Mol Cell. 2004 May 21;14(4):465-77
pubmed: 15149596
Am J Cancer Res. 2018 Oct 01;8(10):2076-2087
pubmed: 30416857
Exp Cell Res. 2018 Sep 15;370(2):551-560
pubmed: 30009791
Stem Cells. 2013 Feb;31(2):282-92
pubmed: 23169579
Cold Spring Harb Perspect Biol. 2012 Feb 01;4(2):
pubmed: 22300977
Dev Biol. 2007 Nov 15;311(2):650-64
pubmed: 17904117
Mol Cell Biol. 2007 Aug;27(16):5910-20
pubmed: 17562853
Sci Rep. 2016 Mar 23;6:23542
pubmed: 27005522
Biochem Biophys Res Commun. 2017 Mar 18;484(4):827-832
pubmed: 28161635
Genomics. 1998 Sep 15;52(3):278-88
pubmed: 9790746
J Cell Physiol. 2010 Sep;224(3):757-65
pubmed: 20578244

Auteurs

Noor Kazim (N)

Department of Biochemistry and Molecular Biology and Simmons Cancer Institute, Southern Illinois University School of Medicine, Carbondale, Illinois, United States of America.

Abhinav Adhikari (A)

Department of Biochemistry and Molecular Biology and Simmons Cancer Institute, Southern Illinois University School of Medicine, Carbondale, Illinois, United States of America.

Judith Davie (J)

Department of Biochemistry and Molecular Biology and Simmons Cancer Institute, Southern Illinois University School of Medicine, Carbondale, Illinois, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH